Hauptmann S - Search Results

1

Prognostic impact of cyclooxygenase-2 in breast cancer.

Denkert C, Winzer KJ, Hauptmann S. Denkert C, et al. Among authors: hauptmann s. Clin Breast Cancer. 2004 Feb;4(6):428-33. doi: 10.3816/cbc.2004.n.006. Clin Breast Cancer. 2004. PMID: 15023244 Review.

2

Elevated expression of cyclooxygenase-2 is a negative prognostic factor for disease free survival and overall survival in patients with breast carcinoma.

Denkert C, Winzer KJ, Müller BM, Weichert W, Pest S, Köbel M, Kristiansen G, Reles A, Siegert A, Guski H, Hauptmann S. Denkert C, et al. Among authors: hauptmann s. Cancer. 2003 Jun 15;97(12):2978-87. doi: 10.1002/cncr.11437. Cancer. 2003. PMID: 12784332 Free article.

3

Induction of G0/G1 cell cycle arrest in ovarian carcinoma cells by the anti-inflammatory drug NS-398, but not by COX-2-specific RNA interference.

Denkert C, Fürstenberg A, Daniel PT, Koch I, Köbel M, Weichert W, Siegert A, Hauptmann S. Denkert C, et al. Among authors: hauptmann s. Oncogene. 2003 Nov 27;22(54):8653-61. doi: 10.1038/sj.onc.1206920. Oncogene. 2003. PMID: 14647459

4

Overexpression of the embryonic-lethal abnormal vision-like protein HuR in ovarian carcinoma is a prognostic factor and is associated with increased cyclooxygenase 2 expression.

Denkert C, Weichert W, Pest S, Koch I, Licht D, Köbel M, Reles A, Sehouli J, Dietel M, Hauptmann S. Denkert C, et al. Among authors: hauptmann s. Cancer Res. 2004 Jan 1;64(1):189-95. doi: 10.1158/0008-5472.can-03-1987. Cancer Res. 2004. PMID: 14729623

5

Expression of the ELAV-like protein HuR is associated with higher tumor grade and increased cyclooxygenase-2 expression in human breast carcinoma.

Denkert C, Weichert W, Winzer KJ, Müller BM, Noske A, Niesporek S, Kristiansen G, Guski H, Dietel M, Hauptmann S. Denkert C, et al. Among authors: hauptmann s. Clin Cancer Res. 2004 Aug 15;10(16):5580-6. doi: 10.1158/1078-0432.CCR-04-0070. Clin Cancer Res. 2004. PMID: 15328200

6

Expression of cyclooxygenase 2 is an independent prognostic factor in human ovarian carcinoma.

Denkert C, Köbel M, Pest S, Koch I, Berger S, Schwabe M, Siegert A, Reles A, Klosterhalfen B, Hauptmann S. Denkert C, et al. Among authors: hauptmann s. Am J Pathol. 2002 Mar;160(3):893-903. doi: 10.1016/S0002-9440(10)64912-7. Am J Pathol. 2002. PMID: 11891188 Free PMC article.

7

Expression of cyclooxygenase 2 in human malignant melanoma.

Denkert C, Köbel M, Berger S, Siegert A, Leclere A, Trefzer U, Hauptmann S. Denkert C, et al. Among authors: hauptmann s. Cancer Res. 2001 Jan 1;61(1):303-8. Cancer Res. 2001. PMID: 11196178

8

An inhibitor of stress-activated MAP-kinases reduces invasion and MMP-2 expression of malignant melanoma cells.

Denkert C, Siegert A, Leclere A, Turzynski A, Hauptmann S. Denkert C, et al. Among authors: hauptmann s. Clin Exp Metastasis. 2002;19(1):79-85. doi: 10.1023/a:1013857325012. Clin Exp Metastasis. 2002. PMID: 11918086

9

CD24 is expressed in ovarian cancer and is a new independent prognostic marker of patient survival.

Kristiansen G, Denkert C, Schlüns K, Dahl E, Pilarsky C, Hauptmann S. Kristiansen G, et al. Among authors: hauptmann s. Am J Pathol. 2002 Oct;161(4):1215-21. doi: 10.1016/S0002-9440(10)64398-2. Am J Pathol. 2002. PMID: 12368195 Free PMC article.

10

Expression of mitogen-activated protein kinase phosphatase-1 (MKP-1) in primary human ovarian carcinoma.

Denkert C, Schmitt WD, Berger S, Reles A, Pest S, Siegert A, Lichtenegger W, Dietel M, Hauptmann S. Denkert C, et al. Among authors: hauptmann s. Int J Cancer. 2002 Dec 10;102(5):507-13. doi: 10.1002/ijc.10746. Int J Cancer. 2002. PMID: 12432554

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

216 results

Search Page

Filters